Actively Recruiting

Phase 3
Age: 12Years +
All Genders
NCT06241118

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

Led by Sanofi · Updated on 2026-05-08

636

Participants Needed

147

Research Sites

239 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study for treatment of participants diagnosed with moderate-to-severe AD on background TCS who have had inadequate response to prior biologic or oral JAKi therapy. The purpose of this study is to measure the efficacy and safety of treatment with amlitelimab solution for subcutaneous (SC) injection compared with placebo in participants with moderate-to-severe AD aged 12 years and older on background TCS and have had an inadequate response to prior biologic or an oral JAKi therapy. Study details include: At the end of the treatment period, participants will have the option to enter the Long-Term Safety Study LTS17367 (RIVER-AD). The study duration will be up to 56 weeks for participants not entering the long-term safety study (LTS17367 \[RIVER-AD\]) including a 2 to 4-week screening, a 36-week randomized double-blind period, and a 16-week safety follow-up. The study duration will be up to 40 weeks for participants entering the long-term safety study (LTS17367 \[RIVER-AD\]) including a 2 to 4-week screening and a 36-week randomized double-blind period. The total treatment duration will be up to 36 weeks. The total number of visits will be up to 13 visits (or 12 visits for those entering the long-term safety study LTS17367 \[RIVER-AD\] study).

CONDITIONS

Official Title

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

Who Can Participate

Age: 12Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be 12 years of age or older when signing the informed consent form
  • Diagnosis of atopic dermatitis for at least 1 year according to American Academy of Dermatology criteria
  • Documented history of inadequate response to biologic AD medication or oral JAK inhibitor therapy before screening
  • Validated Investigator Global Assessment for AD score of 3 or 4 at baseline
  • Eczema Area and Severity Index score of 16 or higher at baseline
  • Atopic dermatitis affecting 10% or more of body surface area at baseline
  • Weekly average of daily peak pruritus numerical rating scale of 4 or higher at baseline
  • Ability and willingness to comply with study visits and procedures
  • Body weight of 25 kilograms or more
Not Eligible

You will not qualify if you...

  • Skin conditions that interfere with atopic dermatitis assessments
  • Known or suspected significant current immunosuppression
  • Any current or past malignancies except non-melanoma skin cancer excised and cured more than 5 years before baseline
  • History of solid organ or stem cell transplant
  • Active or chronic infections requiring systemic treatment within 4 weeks before baseline
  • Positive for HIV, Hepatitis B, or Hepatitis C at screening
  • Active tuberculosis, latent tuberculosis, incomplete or suspected extrapulmonary tuberculosis, or high risk of tuberculosis
  • Receipt of specified therapies within defined timeframes before baseline
  • Clinically significant laboratory abnormalities or results at screening
  • History of allergy or hypersensitivity to study drug or its ingredients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 147 locations

1

University of Alabama at Birmingham- Site Number : 8401267

Birmingham, Alabama, United States, 35233

Actively Recruiting

2

Center for Dermatology and Plastic Surgery- Site Number : 8401119

Scottsdale, Arizona, United States, 85260

Actively Recruiting

3

Arkansas Dermatology - North Little Rock- Site Number : 8401244

North Little Rock, Arkansas, United States, 72117

Actively Recruiting

4

Encino Research Center- Site Number : 8401042

Encino, California, United States, 91436

Actively Recruiting

5

Center for Dermatology Clinical Research- Site Number : 8401018

Fremont, California, United States, 94538

Actively Recruiting

6

Long Beach Clinical Trials- Site Number : 8401188

Long Beach, California, United States, 90806

Actively Recruiting

7

Dermatology Research Associates - Los Angeles- Site Number : 8401092

Los Angeles, California, United States, 90045

Actively Recruiting

8

LA Universal Research Center- Site Number : 8401064

Los Angeles, California, United States, 90057

Actively Recruiting

9

University Dermatology Trials- Site Number : 8401339

Newport Beach, California, United States, 92660

Actively Recruiting

10

Rady Children's Hospital- Site Number : 8401291

San Diego, California, United States, 92123

Actively Recruiting

11

Therapeutics Clinical Research- Site Number : 8401283

San Diego, California, United States, 92123

Actively Recruiting

12

Paradigm Clinical Research - Wheat Ridge- Site Number : 8401245

Wheat Ridge, Colorado, United States, 80033

Actively Recruiting

13

Encore Medical Research of Boynton Beach- Site Number : 8401030

Boynton Beach, Florida, United States, 33436

Actively Recruiting

14

St. Jude Clinical Research- Site Number : 8401287

Doral, Florida, United States, 33172

Actively Recruiting

15

Apex Clinical Research - Jacksonville- Site Number : 8401332

Jacksonville, Florida, United States, 32256

Actively Recruiting

16

Global Clinical Professionals (GCP)- Site Number : 8401045

St. Petersburg, Florida, United States, 33705

Actively Recruiting

17

Avita Clinical Research- Site Number : 8401073

Tampa, Florida, United States, 33613

Actively Recruiting

18

Northwestern University- Site Number : 8401285

Chicago, Illinois, United States, 60611

Actively Recruiting

19

NorthShore University Health System - Endeavor Health Medical Group - Skokie - Woods Drive- Site Number : 8401038

Skokie, Illinois, United States, 60077

Actively Recruiting

20

Dawes Fretzin Clinical Research- Site Number : 8401015

Indianapolis, Indiana, United States, 46256

Actively Recruiting

21

Equity Medical - Bowling Green- Site Number : 8401296

Bowling Green, Kentucky, United States, 42104

Actively Recruiting

22

Tandem Clinical Research - Metairie- Site Number : 8401187

Metairie, Louisiana, United States, 70006

Actively Recruiting

23

University of Michigan Health System - Ann Arbor- Site Number : 8401290

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

24

MI Skin Center- Site Number : 8401307

Northville, Michigan, United States, 48167

Actively Recruiting

25

Skin Specialists- Site Number : 8401068

Omaha, Nebraska, United States, 68144

Actively Recruiting

26

Schweiger Dermatology Group - East Windsor- Site Number : 8401338

East Windsor, New Jersey, United States, 08520

Actively Recruiting

27

The University of New Mexico- Site Number : 8401263

Albuquerque, New Mexico, United States, 87106

Actively Recruiting

28

Equity Medical- Site Number : 8401239

New York, New York, United States, 10023

Actively Recruiting

29

Sadick Research Group - New York - Park Avenue- Site Number : 8401050

New York, New York, United States, 10075

Actively Recruiting

30

Cincinnati Children's Hospital Medical Center- Site Number : 8401279

Cincinnati, Ohio, United States, 45229

Actively Recruiting

31

Oregon Health & Science University (OHSU)- Site Number : 8401247

Portland, Oregon, United States, 97239

Actively Recruiting

32

Paddington Testing Company- Site Number : 8401041

Philadelphia, Pennsylvania, United States, 19103

Actively Recruiting

33

Clinical Research of Philadelphia- Site Number : 8401193

Philadelphia, Pennsylvania, United States, 19114

Actively Recruiting

34

Medical University of South Carolina - Charleston - Jonathan Lucas Street- Site Number : 8401282

Charleston, South Carolina, United States, 29425

Actively Recruiting

35

Arlington Research Center- Site Number : 8401248

Arlington, Texas, United States, 76011

Actively Recruiting

36

McGovern Medical School - UT Physicians Dermatology - Bellaire Station- Site Number : 8401288

Bellaire, Texas, United States, 77401

Actively Recruiting

37

Reveal Research Institute - Dallas- Site Number : 8401219

Dallas, Texas, United States, 75235

Actively Recruiting

38

Advanced Research Institute - Odgen (ARI - Ogden)- Site Number : 8401057

Ogden, Utah, United States, 84405

Actively Recruiting

39

Virginia Dermatology & Skin Cancer Center- Site Number : 8401047

Norfolk, Virginia, United States, 23502

Actively Recruiting

40

North Sound Dermatology- Site Number : 8401280

Mill Creek, Washington, United States, 98012

Actively Recruiting

41

Children's Wisconsin- Site Number : 8401246

Milwaukee, Wisconsin, United States, 53226

Actively Recruiting

42

Cheyenne Skin Clinic- Site Number : 8401234

Cheyenne, Wyoming, United States, 82009

Actively Recruiting

43

Investigational Site Number : 0320007

Rosario, Santa Fe Province, Argentina, 2000

Actively Recruiting

44

Investigational Site Number : 0320011

Buenos Aires, Argentina, 1035

Actively Recruiting

45

Investigational Site Number : 0320019

Buenos Aires, Argentina, 1426

Actively Recruiting

46

Investigational Site Number : 0320014

Córdoba, Argentina, 5000

Actively Recruiting

47

Investigational Site Number : 0360008

Melbourne, Victoria, Australia, 3002

Actively Recruiting

48

Investigational Site Number : 0360006

Melbourne, Victoria, Australia, 3004

Actively Recruiting

49

Centro de Pesquisas da Clínica IBIS- Site Number : 0760002

Salvador, Estado de Bahia, Brazil, 41820-020

Actively Recruiting

50

Irmandade da Santa Casa de Misericórdia de Porto Alegre- Site Number : 0760005

Porto Alegre, Rio Grande do Sul, Brazil, 90020-090

Actively Recruiting

51

Faculdade de Medicina do ABC- Site Number : 0760001

Santo André, São Paulo, Brazil, 09060-650

Actively Recruiting

52

Clinica de Alergia Martti Antila- Site Number : 0760006

Sorocaba, São Paulo, Brazil, 18040-425

Completed

53

Hospital Alemao Oswaldo Cruz - São Paulo- Site Number : 0760010

São Paulo, Brazil, 01323-020

Actively Recruiting

54

Centro de Desenvolvimento em Estudos ClÌnicos Brasil- Site Number : 0760014

São Paulo, Brazil, 04020-060

Actively Recruiting

55

Investigational Site Number : 1240019

Calgary, Alberta, Canada, T2W 4X9

Actively Recruiting

56

Investigational Site Number : 1240016

Edmonton, Alberta, Canada, T5J 3S9

Actively Recruiting

57

Investigational Site Number : 1240058

Burlington, Ontario, Canada, L7L 6W6

Actively Recruiting

58

Investigational Site Number : 1240020

Hamilton, Ontario, Canada, L8L 3C3

Actively Recruiting

59

Investigational Site Number : 1240053

London, Ontario, Canada, N6A 5R9

Actively Recruiting

60

Investigational Site Number : 1240054

Toronto, Ontario, Canada, M5m 3z8

Actively Recruiting

61

Investigational Site Number : 1240028

Regina, Saskatchewan, Canada, S4V 1R9

Actively Recruiting

62

Investigational Site Number : 1520002

Santiago, Reg Metropolitana de Santiago, Chile, 7580206

Actively Recruiting

63

Investigational Site Number : 1520003

Santiago, Reg Metropolitana de Santiago, Chile, 7640881

Actively Recruiting

64

Investigational Site Number : 1520010

Santiago, Reg Metropolitana de Santiago, Chile, 8330034

Actively Recruiting

65

Investigational Site Number : 1520005

Santiago, Reg Metropolitana de Santiago, Chile, 8380465

Actively Recruiting

66

Investigational Site Number : 1520001

Santiago, Reg Metropolitana de Santiago, Chile, 8420383

Actively Recruiting

67

Investigational Site Number : 1560031

Changchun, China, 130021

Actively Recruiting

68

Investigational Site Number : 1560021

Guangzhou, China, 510018

Actively Recruiting

69

Investigational Site Number : 1560036

Guangzhou, China, 510100

Actively Recruiting

70

Investigational Site Number : 1560044

Hangzhou, China, 310003

Actively Recruiting

71

Investigational Site Number : 1560002

Hangzhou, China, 310006

Actively Recruiting

72

Investigational Site Number : 1560009

Hangzhou, China, 310009

Actively Recruiting

73

Investigational Site Number : 1560034

Nanyang, China, 473014

Actively Recruiting

74

Investigational Site Number : 1560024

Ningbo, China, 315010

Actively Recruiting

75

Investigational Site Number : 1560035

Ningbo, China, 315010

Actively Recruiting

76

Investigational Site Number : 1560001

Shanghai, China, 200040

Actively Recruiting

77

Investigational Site Number : 1560005

Shanghai, China, 200443

Actively Recruiting

78

Investigational Site Number : 1560041

Shenyang, China, 110001

Actively Recruiting

79

Investigational Site Number : 1560038

Wuhan, China, 430030

Actively Recruiting

80

Investigational Site Number : 1560032

Xi'an, China, 710004

Actively Recruiting

81

Investigational Site Number : 2500011

Bordeaux, France, 33000

Actively Recruiting

82

Investigational Site Number : 2500014

Clermont-Ferrand, France, 63100

Active, Not Recruiting

83

Investigational Site Number : 2500004

Créteil, France, 94010

Actively Recruiting

84

Investigational Site Number : 2500001

Lille, France, 59037

Actively Recruiting

85

Investigational Site Number : 2500017

Paris, France, 75010

Actively Recruiting

86

Investigational Site Number : 2500012

Rouen, France, 76031

Actively Recruiting

87

Investigational Site Number : 2762203

Berlin, Germany, 10117

Actively Recruiting

88

Investigational Site Number : 2762202

Blankenfelde-Mahlow, Germany, 15831

Actively Recruiting

89

Investigational Site Number : 2761001

Dresden, Germany, 01307

Actively Recruiting

90

Investigational Site Number : 2760022

Frankfurt, Germany, 60590

Actively Recruiting

91

Investigational Site Number : 2761002

Lübeck, Germany, 23562

Actively Recruiting

92

Investigational Site Number : 2760019

Witten, Germany, 58453

Actively Recruiting

93

Investigational Site Number : 3000004

Athens, Greece, 124 62

Actively Recruiting

94

Investigational Site Number : 3000001

Athens, Greece, 16121

Actively Recruiting

95

Investigational Site Number : 3000005

Athens, Greece, 16121

Actively Recruiting

96

Investigational Site Number : 3000002

Thessaloniki, Greece, 54643

Actively Recruiting

97

Investigational Site Number : 3760005

Beersheba, Israel, 8457108

Actively Recruiting

98

Investigational Site Number : 3760008

Ramat Gan, Israel, 5262100

Actively Recruiting

99

Investigational Site Number : 3760007

Tel Aviv, Israel, 6423906

Actively Recruiting

100

Investigational Site Number : 3800020

Turin, Torino, Italy, 10126

Actively Recruiting

101

Center for Advanced Studies and Technology-Site Number: 3800016

Chieti, Italy, 66100

Actively Recruiting

102

A.O.U. di Modena -Site Number: 3800021

Modena, Italy, 41125

Actively Recruiting

103

UOC Clinica Dermatologica - AOU "Luigi Vanvitelli"-Site Number : 3800017

Naples, Italy, 80131

Actively Recruiting

104

Azienda ospedaliera di Perugia - Ospedale "Santa Maria della Misericordia"-Site Number: 3800015

Perugia, Italy, 06129

Actively Recruiting

105

Investigational Site Number : 3923113

Yokohama, Kanagawa, Japan, 221-0825

Actively Recruiting

106

Investigational Site Number : 3923109

Habikino, Osaka, Japan, 583-8588

Actively Recruiting

107

Investigational Site Number : 3923110

Sakai, Osaka, Japan, 593-8324

Actively Recruiting

108

Investigational Site Number : 3923106

Mibu, Tochigi, Japan, 321-0293

Actively Recruiting

109

Investigational Site Number : 3920001

Tachikawa, Tokyo, Japan, 190-0023

Actively Recruiting

110

Investigational Site Number : 3920007

Hiroshima, Japan, 734-8551

Actively Recruiting

111

Investigational Site Number : 4840011

Monterrey, Nuevo León, Mexico, 64460

Actively Recruiting

112

Investigational Site Number : 4840003

Veracruz, Mexico, 91900

Actively Recruiting

113

Investigational Site Number : 6162417

Wroclaw, Lower Silesian Voivodeship, Poland, 51-685

Actively Recruiting

114

Investigational Site Number : 6160002

Lublin, Lublin Voivodeship, Poland, 20-363

Actively Recruiting

115

Investigational Site Number : 6162411

Warsaw, Masovian Voivodeship, Poland, 01-142

Actively Recruiting

116

Investigational Site Number : 6160001

Warsaw, Masovian Voivodeship, Poland, 02-507

Actively Recruiting

117

Investigational Site Number : 6160006

Gdansk, Pomeranian Voivodeship, Poland, 80-546

Actively Recruiting

118

Investigational Site Number : 2500016

Saint-Pierre, Reunion, 97448

Actively Recruiting

119

Investigational Site Number : 6820001

Riyadh, Saudi Arabia, 12713

Actively Recruiting

120

Investigational Site Number : 4100002

Ansan-si, Gyeonggi-do, South Korea, 15355

Actively Recruiting

121

Investigational Site Number : 4100014

Seongnam-si, Gyeonggi-do, South Korea, 13620

Actively Recruiting

122

Investigational Site Number : 4100015

Bupyeong-Gu, Incheon-gwangyeoksi, South Korea, 21431

Actively Recruiting

123

Investigational Site Number : 4100007

Seoul, Seoul-teukbyeolsi, South Korea, 03722

Actively Recruiting

124

Investigational Site Number : 4100001

Seoul, Seoul-teukbyeolsi, South Korea, 07441

Actively Recruiting

125

Investigational Site Number : 7240002

Badalona, Barcelona [Barcelona], Spain, 08916

Actively Recruiting

126

Investigational Site Number : 7240017

Majadahonda, Madrid, Spain, 28222

Actively Recruiting

127

Investigational Site Number : 7240020

Seville, Sevilla, Spain, 41013

Actively Recruiting

128

Investigational Site Number : 7242505

Alicante, Spain, 03010

Actively Recruiting

129

Investigational Site Number : 7242503

Madrid, Spain, 28046

Actively Recruiting

130

Investigational Site Number : 1583201

Kaohsiung City, Taiwan, 833

Active, Not Recruiting

131

Investigational Site Number : 1580001

Taipei, Taiwan, 100

Actively Recruiting

132

Investigational Site Number : 1580003

Taipei, Taiwan

Actively Recruiting

133

Investigational Site Number : 1583203

Taoyuan City, Taiwan, 333

Actively Recruiting

134

Investigational Site Number : 7920008

Gaziantep, Turkey (Türkiye), 27310

Actively Recruiting

135

Investigational Site Number : 7920005

Istanbul, Turkey (Türkiye), 34093

Actively Recruiting

136

Investigational Site Number : 7920002

Istanbul, Turkey (Türkiye), 34098

Actively Recruiting

137

Investigational Site Number : 7841002

Abu Dhabi, United Arab Emirates, 51900

Actively Recruiting

138

Investigational Site Number : 7840001

Abu Dhabi, United Arab Emirates, 6222

Actively Recruiting

139

Investigational Site Number : 7840002

Abu Dhabi, United Arab Emirates

Actively Recruiting

140

Investigational Site Number : 8260013

Bristol, Bristol, City of, United Kingdom, BS2 8HW

Actively Recruiting

141

Investigational Site Number : 8260012

Plymouth, Devon, United Kingdom, PL6 8DH

Actively Recruiting

142

Investigational Site Number : 8262603

London, England, United Kingdom, E11 1NR

Actively Recruiting

143

Investigational Site Number : 8260015

London, England, United Kingdom, SW10 9NH

Actively Recruiting

144

Investigational Site Number : 8260003

Portsmouth, Hampshire, United Kingdom, PO3 6DW

Actively Recruiting

145

Investigational Site Number : 8260009

Leeds, North Yorkshire, United Kingdom, Ls7 4sa

Actively Recruiting

146

Investigational Site Number : 8260010

Nottingham, Nottinghamshire, United Kingdom, NG17 4JL

Actively Recruiting

147

Investigational Site Number : 8260008

Liverpool, United Kingdom, L7 8XP

Actively Recruiting

Loading map...

Research Team

T

Trial Transparency email recommended (Toll free for US & Canada)

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor | DecenTrialz